Sit Investment Associates’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $81K | Hold |
900
| – | – | ﹤0.01% | 462 |
|
|
2025
Q4 | $81K | Sell |
900
-37,858
| -98% | -$3.59M | ﹤0.01% | 477 |
|
|
2025
Q3 | $3.82M | Buy |
38,758
+15,851
| +69% | +$1.57M | 0.08% | 232 |
|
|
2025
Q2 | $2.09M | Sell |
22,907
-17,755
| -44% | -$1.72M | 0.04% | 301 |
|
|
2025
Q1 | $4.6M | Sell |
40,662
-6,770
| -14% | -$724K | 0.11% | 202 |
|
|
2024
Q4 | $5.01M | Sell |
47,432
-34,935
| -42% | -$3.75M | 0.11% | 204 |
|
|
2024
Q3 | $8.89M | Sell |
82,367
-19,670
| -19% | -$2.15M | 0.2% | 144 |
|
|
2024
Q2 | $11.1M | Buy |
102,037
+18,180
| +22% | +$2.14M | 0.25% | 115 |
|
|
2024
Q1 | $11.1M | Buy |
83,857
+9,910
| +13% | +$1.24M | 0.25% | 115 |
|
|
2023
Q4 | $9M | Sell |
73,947
-10,445
| -12% | -$1.17M | 0.22% | 140 |
|
|
2023
Q3 | $9.47M | Buy |
84,392
+46,615
| +123% | +$5.92M | 0.26% | 118 |
|
|
2023
Q2 | $5.5M | Buy |
37,777
+35,510
| +1,566% | +$4.83M | 0.14% | 183 |
|
|
2023
Q1 | $293K | Sell |
2,267
-250
| -10% | -$31.4K | 0.01% | 446 |
|
|
2022
Q4 | $321K | Sell |
2,517
-175
| -7% | -$20.3K | 0.01% | 435 |
|
|
2022
Q3 | $281K | Buy |
2,692
+260
| +11% | +$28.5K | 0.01% | 427 |
|
|
2022
Q2 | $256K | Hold |
2,432
| – | – | 0.01% | 428 |
|
|
2022
Q1 | $311K | Sell |
2,432
-73
| -3% | -$8.8K | 0.01% | 436 |
|
|
2021
Q4 | $309K | Sell |
2,505
-75,319
| -97% | -$9.86M | 0.01% | 446 |
|
|
2021
Q3 | $11.1M | Buy |
77,824
+5,557
| +8% | +$817K | 0.29% | 110 |
|
|
2021
Q2 | $11.3M | Buy |
72,267
+20,245
| +39% | +$3.28M | 0.28% | 113 |
|
|
2021
Q1 | $8.09M | Buy |
52,022
+329
| +0.6% | +$51K | 0.21% | 143 |
|
|
2020
Q4 | $7.73M | Sell |
51,693
-3,412
| -6% | -$482K | 0.21% | 147 |
|
|
2020
Q3 | $7.28M | Sell |
55,105
-4,238
| -7% | -$554K | 0.21% | 138 |
|
|
2020
Q2 | $6.88M | Sell |
59,343
-18,762
| -24% | -$2.16M | 0.22% | 136 |
|
|
2020
Q1 | $7.67M | Sell |
78,105
-6,808
| -8% | -$892K | 0.29% | 103 |
|
|
2019
Q4 | $12.3M | Sell |
84,913
-10,027
| -11% | -$1.38M | 0.35% | 82 |
|
|
2019
Q3 | $12.7M | Sell |
94,940
-7,708
| -8% | -$996K | 0.39% | 72 |
|
|
2019
Q2 | $11.7M | Buy |
102,648
+14,737
| +17% | +$1.73M | 0.36% | 81 |
|
|
2019
Q1 | $10.9M | Buy |
87,911
+26,014
| +42% | +$2.96M | 0.35% | 94 |
|
|
2018
Q4 | $6.23M | Buy |
61,897
+27,469
| +80% | +$3.09M | 0.2% | 140 |
|
|
2018
Q3 | $4.39M | Buy |
+34,428
| New | +$4.09M | 0.11% | 182 |
|
|
2017
Q3 | – | Sell |
-34,654
| Closed | -$4.32M | – | 675 |
|
|
2017
Q2 | $4.32M | Sell |
34,654
-126,021
| -78% | -$14.9M | 0.11% | 192 |
|
|
2017
Q1 | $19M | Sell |
160,675
-16,377
| -9% | -$1.86M | 0.48% | 82 |
|
|
2016
Q4 | $17.7M | Sell |
177,052
-17,525
| -9% | -$1.88M | 0.46% | 82 |
|
|
2016
Q3 | $24.6M | Sell |
194,577
-9,275
| -5% | -$1.15M | 0.65% | 49 |
|
|
2016
Q2 | $23.8M | Sell |
203,852
-193,836
| -49% | -$21.9M | 0.63% | 54 |
|
|
2016
Q1 | $41.2M | Buy |
397,688
+4,425
| +1% | +$428K | 0.75% | 46 |
|
|
2015
Q4 | $39.2M | Buy |
393,263
+14,244
| +4% | +$1.39M | 0.73% | 47 |
|
|
2015
Q3 | $34.6M | Buy |
379,019
+102,485
| +37% | +$10.3M | 0.65% | 61 |
|
|
2015
Q2 | $29.3M | Sell |
276,534
-203,709
| -42% | -$22.5M | 0.54% | 76 |
|
|
2015
Q1 | $54.8M | Sell |
480,243
-29,148
| -6% | -$3.33M | 0.95% | 25 |
|
|
2014
Q4 | $56.1M | Buy |
+509,391
| New | +$53.7M | 0.93% | 24 |
|
Other funds holding ZBH
VCM
VPM
Sit Investment Associates's ZBH Position: Q1 2026 in Review
Sit Investment Associates held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 900 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #462.
Sit Investment Associates first reported a position in ZBH in Q4 2014 and has held it in 42 quarters since. The position peaked at $56.1M in Q4 2014. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Sit Investment Associates held 900 shares of Zimmer Biomet worth $81K as of Q1 2026.
- Sit Investment Associates left its Zimmer Biomet share count unchanged in Q1 2026.
- Zimmer Biomet made up ﹤0.01% of Sit Investment Associates's portfolio in Q1 2026, its #462 holding.
- Sit Investment Associates first reported a position in Zimmer Biomet in Q4 2014 and has held it in 42 quarters since.
- Sit Investment Associates's Zimmer Biomet position peaked at $56.1M in Q4 2014.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Sit Investment Associates's 13F filing for Q1 2026, filed 13 May 2026.